Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.9210
-0.0218 (-2.31%)
At close: Sep 11, 2026, 4:00 PM EDT
0.9010
-0.0200 (-2.17%)
After-hours: Sep 11, 2026, 7:38 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $2.1 million as of September 11, 2026. Its market cap has decreased by -90.50% in one year.
Market Cap
2.10M
Enterprise Value
2.23M
1-Year Change
-90.50%
Ranking
Category
Stock Price
$0.92
ChartMarket Cap Chart
Since February 10, 2023, Propanc Biopharma's market cap has increased from $571.43K to $2.10M, an increase of 267.22%. That is a compound annual growth rate of 43.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.10M | -70.74% |
| Dec 31, 2025 | 7.17M | 4,231.28% |
| Dec 31, 2024 | 165.57K | -48.84% |
| Dec 29, 2023 | 323.62K | -43.37% |
| Feb 10, 2023 | 571.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 2.96M |
| SciSparc | 2.90M |
| Matinas BioPharma Holdings | 2.77M |
| Genprex | 2.75M |
| Curis | 2.46M |
| Jupiter Neurosciences | 2.40M |
| Oragenics | 2.28M |
| Virax Biolabs Group | 2.26M |